This triggers our immune system to produce antibodies and activate other immune cells to fight off what it thinks is an infection. Our immune system recognizes that the protein does not belong there. Next, our cells display the spike protein piece on their surface.After the protein piece is made, our cells break down the mRNA and remove it, leaving the body as waste. The spike protein is found on the surface of the virus that causes COVID-19. Once inside, they use the cells’ machinery to produce a harmless piece of what is called the spike protein. After vaccination, the mRNA will enter the muscle cells.First, mRNA COVID-19 vaccines are given in the upper arm muscle or upper thigh, depending on the age of who is getting vaccinated.Like vaccine authorizations, Health Canada will always make treatment authorization decisions based on the best scientific evidence. Health Canada is fast-tracking the review of COVID-19 treatments by using similar review processes as those for vaccines. Find out about COVID-19 treatments that are authorized in Canada. There are also potential COVID-19 treatments that are being assessed in clinical trials. These measures will help make safe and effective vaccines and treatments available faster in Canada. demonstrates that the benefits outweigh the risks.is safe, effective and of good quality and.We'll then decide whether to authorize the COVID-19 vaccine and will only do so when the evidence shows that the vaccine: However, Health Canada will always make independent, science-based decisions that are in the best interest of the public.Īs for all vaccines and treatments that are authorized in Canada, we'll review the evidence and scientific data.
We're also working with international regulators to collaborate on the review process to get vaccines to market as quickly as possible. We've dedicated more scientific resources to complete these reviews so that they're done quickly but without cutting corners.Ī similar process was used in 2009 to review and authorize the H1N1 pandemic vaccine. We are also able to review any new evidence as it becomes available, instead of waiting until all studies are completed.
If manufacturers apply through the interim order process, we're able to start the review process right away. Health Canada has put in place a fast-tracked review process to assess COVID-19 vaccines. this process was set up to respond to the urgent need for COVID-19 drugs during the pandemic.the interim order for COVID-19 drug authorization.They must use one of the following regulatory processes: To market a vaccine in Canada, the manufacturer must file an application to Health Canada. The benefits must also outweigh any risks. Our decisions are based only on scientific and medical evidence showing that vaccines are safe and effective. Health Canada's independent drug authorization process is recognized around the world for its high standards and rigorous review. You can search the complete list of drugs and vaccines that have been authorized for treating and preventing COVID-19. On December 9, 2020, we authorized the first vaccine in Canada for the prevention of COVID-19.įind out about COVID-19 vaccines that are authorized in Canada. Right now, there are more than 150 potential COVID-19 vaccines at different stages of development around the world.
international collaboration among scientists, health professionals, researchers, industry and governments.However, the development of vaccines for COVID-19 is progressing quickly for many reasons, including: Health Canada is prioritizing the review of all COVID-19 drugs and vaccines.Ĭreating a new vaccine can take years. Having safe and effective COVID-19 vaccines available will be an important tool to help with the long-term management of COVID-19. This partnership between private industry and the public can lead to more affordable and ground-breaking health products for Canada. Manufacturers manage the process for vaccine production.īoth private and large public investments from governments around the world are being put toward research and development of COVID-19 vaccines. Our investments in research will help make sure Canada has faster access to safe and effective vaccines. It requires significant investments to ensure it can be produced on a large scale with good quality and consistency. Videos, posters and infographics to share.
0 kommentar(er)
